Every participants journey is different, and individual results should never be compared directly with someone elses experience
If youre injecting semaglutide yourself, for instance, you might have trouble reaching the back of your upper armso you can rotate through both of your thighs and abdomen instead
Research Snapshot: Current State of Research Semaglutide has been examined extensively in GLP-1 receptor pharmacology, glucose-regulation research, appetite and gastric-emptying studies, cardiovascular-outcome research, body-weight trials, kidney-outcome research, and peptide-formulation studies
they are selling verified results and stability
On average, GLP-1 use leads to a modest amount of weight loss, averaging between 5-10% of body weight, while some users may not experience any weight changes
Azran C, Porat D, Fine-Shamir N, Hanhan N, Dahan A